 treatment small-cel lung cancer chemotherapi regimen weekli interv southwest oncolog group pilot studi intens weekli treatment regimen patient small-cel lung cancer sclc activ chemotherapeut agent diseas doxorubicin dox cyclophosphamid ctx vincristin vcr cisplatin cddp mtx goal program rapid repetit exposur activ drug treatment total week seventy-six sclc patient limit diseas extens diseas overal complet partial respons rate complet respons rate patient limit LD extens diseas ED median surviv patient LD ED month toxic toler twenty-six patient transient life-threaten toxic patient fatal toxic eighty-four percent patient protocol entir treatment period intens short-dur treatment regimen good standard regimen complet respons rate median surviv patient ED sclc